Young age and the risk for ifosfamide-induced nephrotoxicity: a critical review of two opposing studies View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2001-12

AUTHORS

K. Aleksa, C. Woodland, G. Koren

ABSTRACT

Ifosfamide has been in use as an effective antineoplastic agent for solid tumors in both children and adults since the late 1960s. Although some adverse effects (e.g. hemorrhagic cystitis) can be overcome by the co-administration of 2-mercaptoethanesulfonate (MESNA), others such as nephrotoxicity cannot. There is a consensus that factors such as the cumulative dose of ifosfamide and concomitant cisplatin administration may influence not only the incidence but also the severity of ifosfamide-induced renal toxicity. Several preliminary studies suggested young age as a risk factor for nephrotoxicity; however, there is little agreement on this. The reasons for this uncertainty may include sample size, study design, dose and differences in renal function assessment. In this review we examine the two largest cohort studies conducted in pediatric patients. One study suggests that ifosfamide-induced renal toxicity is age- related, whereas analysis of the other failed to show age as an important predictor for ifosfamide-induced renal toxicity. The studies differed in design, end-points of toxicity and concomitant drug therapy. Due to the effectiveness of ifosfamide as an antineoplastic agent, it is important that an understanding of the factors that predispose pediatric patients to ifosfamide-induced nephrotoxicity be obtained. More... »

PAGES

1153-1158

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s004670100053

DOI

http://dx.doi.org/10.1007/s004670100053

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1005325948

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11793120


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ifosfamide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunosuppressive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kidney", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Hospital for Sick Children", 
          "id": "https://www.grid.ac/institutes/grid.42327.30", 
          "name": [
            "Division of Clinical Pharmacology and Toxicology, Hospital for Sick Children, 555 University Avenue, Toronto, Canada. Gkoren@sickkids.on.ca, CA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aleksa", 
        "givenName": "K.", 
        "id": "sg:person.01255434721.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255434721.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital for Sick Children", 
          "id": "https://www.grid.ac/institutes/grid.42327.30", 
          "name": [
            "Division of Clinical Pharmacology and Toxicology, Hospital for Sick Children, 555 University Avenue, Toronto, Canada. Gkoren@sickkids.on.ca, CA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Woodland", 
        "givenName": "C.", 
        "id": "sg:person.01272116261.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272116261.62"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital for Sick Children", 
          "id": "https://www.grid.ac/institutes/grid.42327.30", 
          "name": [
            "Division of Clinical Pharmacology and Toxicology, Hospital for Sick Children, 555 University Avenue, Toronto, Canada. Gkoren@sickkids.on.ca, CA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Koren", 
        "givenName": "G.", 
        "id": "sg:person.0755720172.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0755720172.61"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf01959214", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000759505", 
          "https://doi.org/10.1007/bf01959214"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01959214", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000759505", 
          "https://doi.org/10.1007/bf01959214"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0305-7372(85)90011-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001184954"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(89)90341-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005025172"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(89)90341-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005025172"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003495-199142030-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005265704", 
          "https://doi.org/10.2165/00003495-199142030-00006"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(88)91942-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005479892"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(88)91942-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005479892"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0031-3955(16)36251-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005703061"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-2952(94)90387-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009814829"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-2952(94)90387-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009814829"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(96)03480-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010610173"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0163-7258(88)90004-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015042973"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0163-7258(88)90004-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015042973"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1054/bjoc.2000.1214", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019201618", 
          "https://doi.org/10.1054/bjoc.2000.1214"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00866300", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027478341", 
          "https://doi.org/10.1007/bf00866300"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(86)92227-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031397759"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-2952(93)90310-s", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031553370"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-2952(93)90310-s", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031553370"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(89)90213-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045161027"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(89)90213-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045161027"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/009127009903900504", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045218394"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s002800050393", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047809476", 
          "https://doi.org/10.1007/s002800050393"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00865464", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050771333", 
          "https://doi.org/10.1007/bf00865464"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/(sici)1096-911x(199902)32:2<93::aid-mpo4>3.0.co;2-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051345837"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1993.11.1.173", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082798654"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2001-12", 
    "datePublishedReg": "2001-12-01", 
    "description": "Ifosfamide has been in use as an effective antineoplastic agent for solid tumors in both children and adults since the late 1960s. Although some adverse effects (e.g. hemorrhagic cystitis) can be overcome by the co-administration of 2-mercaptoethanesulfonate (MESNA), others such as nephrotoxicity cannot. There is a consensus that factors such as the cumulative dose of ifosfamide and concomitant cisplatin administration may influence not only the incidence but also the severity of ifosfamide-induced renal toxicity. Several preliminary studies suggested young age as a risk factor for nephrotoxicity; however, there is little agreement on this. The reasons for this uncertainty may include sample size, study design, dose and differences in renal function assessment. In this review we examine the two largest cohort studies conducted in pediatric patients. One study suggests that ifosfamide-induced renal toxicity is age- related, whereas analysis of the other failed to show age as an important predictor for ifosfamide-induced renal toxicity. The studies differed in design, end-points of toxicity and concomitant drug therapy. Due to the effectiveness of ifosfamide as an antineoplastic agent, it is important that an understanding of the factors that predispose pediatric patients to ifosfamide-induced nephrotoxicity be obtained.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s004670100053", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1097267", 
        "issn": [
          "0931-041X", 
          "1432-198X"
        ], 
        "name": "Pediatric Nephrology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "12", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "16"
      }
    ], 
    "name": "Young age and the risk for ifosfamide-induced nephrotoxicity: a critical review of two opposing studies", 
    "pagination": "1153-1158", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "195fdce733fafd89ea390931c8f6d23b70f3834d514505c2feca06f28b437c22"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11793120"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8708728"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s004670100053"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1005325948"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s004670100053", 
      "https://app.dimensions.ai/details/publication/pub.1005325948"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T16:35", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8669_00000486.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s004670100053"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s004670100053'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s004670100053'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s004670100053'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s004670100053'


 

This table displays all metadata directly associated to this object as RDF triples.

174 TRIPLES      21 PREDICATES      55 URIs      28 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s004670100053 schema:about N0119d6434fa84c78b7c2c6ae2e879a66
2 N0160995a2ca148a6bc90e01c179d9f0d
3 N412a438d1d8b4ae3bfa05f0a7c629887
4 N4457ff248bfc4dc2ba5b657b2cdc3b4e
5 N496b66bc7a2d4bf69bd31c18a33362dc
6 N905c4e1c33e84bb095ef07f51cd4a93a
7 Nc3072cd24a8a427aa816e2d1205adf01
8 anzsrc-for:11
9 anzsrc-for:1103
10 schema:author N0ac80c9a90e84bf3ae5468fc66523f65
11 schema:citation sg:pub.10.1007/bf00865464
12 sg:pub.10.1007/bf00866300
13 sg:pub.10.1007/bf01959214
14 sg:pub.10.1007/s002800050393
15 sg:pub.10.1054/bjoc.2000.1214
16 sg:pub.10.2165/00003495-199142030-00006
17 https://doi.org/10.1002/(sici)1096-911x(199902)32:2<93::aid-mpo4>3.0.co;2-y
18 https://doi.org/10.1016/0006-2952(93)90310-s
19 https://doi.org/10.1016/0006-2952(94)90387-5
20 https://doi.org/10.1016/0163-7258(88)90004-6
21 https://doi.org/10.1016/0305-7372(85)90011-8
22 https://doi.org/10.1016/s0031-3955(16)36251-4
23 https://doi.org/10.1016/s0140-6736(86)92227-0
24 https://doi.org/10.1016/s0140-6736(88)91942-3
25 https://doi.org/10.1016/s0140-6736(89)90213-4
26 https://doi.org/10.1016/s0140-6736(89)90341-3
27 https://doi.org/10.1016/s0140-6736(96)03480-0
28 https://doi.org/10.1177/009127009903900504
29 https://doi.org/10.1200/jco.1993.11.1.173
30 schema:datePublished 2001-12
31 schema:datePublishedReg 2001-12-01
32 schema:description Ifosfamide has been in use as an effective antineoplastic agent for solid tumors in both children and adults since the late 1960s. Although some adverse effects (e.g. hemorrhagic cystitis) can be overcome by the co-administration of 2-mercaptoethanesulfonate (MESNA), others such as nephrotoxicity cannot. There is a consensus that factors such as the cumulative dose of ifosfamide and concomitant cisplatin administration may influence not only the incidence but also the severity of ifosfamide-induced renal toxicity. Several preliminary studies suggested young age as a risk factor for nephrotoxicity; however, there is little agreement on this. The reasons for this uncertainty may include sample size, study design, dose and differences in renal function assessment. In this review we examine the two largest cohort studies conducted in pediatric patients. One study suggests that ifosfamide-induced renal toxicity is age- related, whereas analysis of the other failed to show age as an important predictor for ifosfamide-induced renal toxicity. The studies differed in design, end-points of toxicity and concomitant drug therapy. Due to the effectiveness of ifosfamide as an antineoplastic agent, it is important that an understanding of the factors that predispose pediatric patients to ifosfamide-induced nephrotoxicity be obtained.
33 schema:genre research_article
34 schema:inLanguage en
35 schema:isAccessibleForFree false
36 schema:isPartOf N502d2179310b4ffcadd2d6902048bf2d
37 Naa75540177ba44c181faba209395e8ee
38 sg:journal.1097267
39 schema:name Young age and the risk for ifosfamide-induced nephrotoxicity: a critical review of two opposing studies
40 schema:pagination 1153-1158
41 schema:productId N03a55458f8b04e7f9531292f7144bd53
42 N15bf9218e8344a829d614270226c2d91
43 N4d3889f5edc149f5829e230eaf362479
44 N77b1b1216309419a97cfbb6710e82396
45 N83af7d417e5141f982b985ba10c077ed
46 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005325948
47 https://doi.org/10.1007/s004670100053
48 schema:sdDatePublished 2019-04-10T16:35
49 schema:sdLicense https://scigraph.springernature.com/explorer/license/
50 schema:sdPublisher Ndc06212f06594b41b1034ef96f859f77
51 schema:url http://link.springer.com/10.1007/s004670100053
52 sgo:license sg:explorer/license/
53 sgo:sdDataset articles
54 rdf:type schema:ScholarlyArticle
55 N0119d6434fa84c78b7c2c6ae2e879a66 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
56 schema:name Dose-Response Relationship, Drug
57 rdf:type schema:DefinedTerm
58 N0160995a2ca148a6bc90e01c179d9f0d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
59 schema:name Kidney
60 rdf:type schema:DefinedTerm
61 N03a55458f8b04e7f9531292f7144bd53 schema:name pubmed_id
62 schema:value 11793120
63 rdf:type schema:PropertyValue
64 N0ac80c9a90e84bf3ae5468fc66523f65 rdf:first sg:person.01255434721.05
65 rdf:rest Nc6c31fc040b54c559a7c475dbf5b8016
66 N15bf9218e8344a829d614270226c2d91 schema:name dimensions_id
67 schema:value pub.1005325948
68 rdf:type schema:PropertyValue
69 N412a438d1d8b4ae3bfa05f0a7c629887 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Ifosfamide
71 rdf:type schema:DefinedTerm
72 N4457ff248bfc4dc2ba5b657b2cdc3b4e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Immunosuppressive Agents
74 rdf:type schema:DefinedTerm
75 N496b66bc7a2d4bf69bd31c18a33362dc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Risk Factors
77 rdf:type schema:DefinedTerm
78 N4d3889f5edc149f5829e230eaf362479 schema:name readcube_id
79 schema:value 195fdce733fafd89ea390931c8f6d23b70f3834d514505c2feca06f28b437c22
80 rdf:type schema:PropertyValue
81 N502d2179310b4ffcadd2d6902048bf2d schema:volumeNumber 16
82 rdf:type schema:PublicationVolume
83 N77b1b1216309419a97cfbb6710e82396 schema:name nlm_unique_id
84 schema:value 8708728
85 rdf:type schema:PropertyValue
86 N83af7d417e5141f982b985ba10c077ed schema:name doi
87 schema:value 10.1007/s004670100053
88 rdf:type schema:PropertyValue
89 N905c4e1c33e84bb095ef07f51cd4a93a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Humans
91 rdf:type schema:DefinedTerm
92 Naa75540177ba44c181faba209395e8ee schema:issueNumber 12
93 rdf:type schema:PublicationIssue
94 Nc3072cd24a8a427aa816e2d1205adf01 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Aging
96 rdf:type schema:DefinedTerm
97 Nc6c31fc040b54c559a7c475dbf5b8016 rdf:first sg:person.01272116261.62
98 rdf:rest Necbe23fe2d2345bba0d80a157fa54414
99 Ndc06212f06594b41b1034ef96f859f77 schema:name Springer Nature - SN SciGraph project
100 rdf:type schema:Organization
101 Necbe23fe2d2345bba0d80a157fa54414 rdf:first sg:person.0755720172.61
102 rdf:rest rdf:nil
103 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
104 schema:name Medical and Health Sciences
105 rdf:type schema:DefinedTerm
106 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
107 schema:name Clinical Sciences
108 rdf:type schema:DefinedTerm
109 sg:journal.1097267 schema:issn 0931-041X
110 1432-198X
111 schema:name Pediatric Nephrology
112 rdf:type schema:Periodical
113 sg:person.01255434721.05 schema:affiliation https://www.grid.ac/institutes/grid.42327.30
114 schema:familyName Aleksa
115 schema:givenName K.
116 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255434721.05
117 rdf:type schema:Person
118 sg:person.01272116261.62 schema:affiliation https://www.grid.ac/institutes/grid.42327.30
119 schema:familyName Woodland
120 schema:givenName C.
121 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272116261.62
122 rdf:type schema:Person
123 sg:person.0755720172.61 schema:affiliation https://www.grid.ac/institutes/grid.42327.30
124 schema:familyName Koren
125 schema:givenName G.
126 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0755720172.61
127 rdf:type schema:Person
128 sg:pub.10.1007/bf00865464 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050771333
129 https://doi.org/10.1007/bf00865464
130 rdf:type schema:CreativeWork
131 sg:pub.10.1007/bf00866300 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027478341
132 https://doi.org/10.1007/bf00866300
133 rdf:type schema:CreativeWork
134 sg:pub.10.1007/bf01959214 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000759505
135 https://doi.org/10.1007/bf01959214
136 rdf:type schema:CreativeWork
137 sg:pub.10.1007/s002800050393 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047809476
138 https://doi.org/10.1007/s002800050393
139 rdf:type schema:CreativeWork
140 sg:pub.10.1054/bjoc.2000.1214 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019201618
141 https://doi.org/10.1054/bjoc.2000.1214
142 rdf:type schema:CreativeWork
143 sg:pub.10.2165/00003495-199142030-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005265704
144 https://doi.org/10.2165/00003495-199142030-00006
145 rdf:type schema:CreativeWork
146 https://doi.org/10.1002/(sici)1096-911x(199902)32:2<93::aid-mpo4>3.0.co;2-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1051345837
147 rdf:type schema:CreativeWork
148 https://doi.org/10.1016/0006-2952(93)90310-s schema:sameAs https://app.dimensions.ai/details/publication/pub.1031553370
149 rdf:type schema:CreativeWork
150 https://doi.org/10.1016/0006-2952(94)90387-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009814829
151 rdf:type schema:CreativeWork
152 https://doi.org/10.1016/0163-7258(88)90004-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015042973
153 rdf:type schema:CreativeWork
154 https://doi.org/10.1016/0305-7372(85)90011-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001184954
155 rdf:type schema:CreativeWork
156 https://doi.org/10.1016/s0031-3955(16)36251-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005703061
157 rdf:type schema:CreativeWork
158 https://doi.org/10.1016/s0140-6736(86)92227-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031397759
159 rdf:type schema:CreativeWork
160 https://doi.org/10.1016/s0140-6736(88)91942-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005479892
161 rdf:type schema:CreativeWork
162 https://doi.org/10.1016/s0140-6736(89)90213-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045161027
163 rdf:type schema:CreativeWork
164 https://doi.org/10.1016/s0140-6736(89)90341-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005025172
165 rdf:type schema:CreativeWork
166 https://doi.org/10.1016/s0140-6736(96)03480-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010610173
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1177/009127009903900504 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045218394
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1200/jco.1993.11.1.173 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082798654
171 rdf:type schema:CreativeWork
172 https://www.grid.ac/institutes/grid.42327.30 schema:alternateName Hospital for Sick Children
173 schema:name Division of Clinical Pharmacology and Toxicology, Hospital for Sick Children, 555 University Avenue, Toronto, Canada. Gkoren@sickkids.on.ca, CA
174 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...